ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 679,33
0,05%
Dow Jones
39 375,87
0,17%
DAX
18 520,36
0,32%
Brent Oil
85,67
-0,97%
Bitcoin
57 234,39
2,48%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. HilleVax Inc (HLVX)

  7. HilleVax Inc (HLVX) Actualités

HLVX

HilleVax (HLVX)

HilleVax Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:HLVX
DateHeureSourceTitreSymboleSociété
10/06/202422h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HLVXHilleVax Inc
10/05/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:HLVXHilleVax Inc
09/05/202422h15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:HLVXHilleVax Inc
09/05/202422h05GlobeNewswire Inc.HilleVax Reports First Quarter 2024 Financial Results and Highlights Recent Company ProgressNASDAQ:HLVXHilleVax Inc
20/03/202421h00GlobeNewswire Inc.HilleVax Reports Full Year 2023 Financial Results and Highlights Recent Company ProgressNASDAQ:HLVXHilleVax Inc
13/02/202401h35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HLVXHilleVax Inc
05/02/202422h05GlobeNewswire Inc.HilleVax to Present at Guggenheim 6th Annual Biotechnology ConferenceNASDAQ:HLVXHilleVax Inc
26/01/202423h00Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:HLVXHilleVax Inc
18/01/202413h49Dow Jones NewsHilleVax Taps Sean McLoughlin as Chief Operating OfficerNASDAQ:HLVXHilleVax Inc
18/01/202413h00GlobeNewswire Inc.HilleVax Announces Executive Management Appointment of Sean McLoughlin as Chief Operating OfficerNASDAQ:HLVXHilleVax Inc
08/01/202413h00GlobeNewswire Inc.HilleVax and Kangh Announce Exclusive License Agreement for Hexavalent VLP Norovirus Vaccine Candidate Outside of ChinaNASDAQ:HLVXHilleVax Inc
04/01/202400h28GlobeNewswire Inc.HilleVax to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:HLVXHilleVax Inc
18/12/202323h28Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:HLVXHilleVax Inc
09/11/202322h05GlobeNewswire Inc.HilleVax Reports Third Quarter 2023 Financial Results and Highlights Recent Company ProgressNASDAQ:HLVXHilleVax Inc
01/11/202321h48GlobeNewswire Inc.HilleVax to Present at Upcoming Investor ConferencesNASDAQ:HLVXHilleVax Inc
26/09/202322h01GlobeNewswire Inc.HilleVax to Participate in Fireside Chat at the 2023 Cantor Global Healthcare ConferenceNASDAQ:HLVXHilleVax Inc
25/09/202313h00GlobeNewswire Inc.HilleVax Announces Closing of Public Offering of Common Stock and Full Exercise of the Underwriters’ Option to Purchase Additional SharesNASDAQ:HLVXHilleVax Inc
20/09/202322h01Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:HLVXHilleVax Inc
20/09/202302h05GlobeNewswire Inc.HilleVax Announces Pricing of Public Offering of Common StockNASDAQ:HLVXHilleVax Inc
19/09/202322h09GlobeNewswire Inc.HilleVax Announces Proposed Public Offering of Common StockNASDAQ:HLVXHilleVax Inc
14/08/202313h00GlobeNewswire Inc.HilleVax Reports Second Quarter 2023 Financial Results and Highlights Recent Company ProgressNASDAQ:HLVXHilleVax Inc
22/06/202322h06Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:HLVXHilleVax Inc
21/06/202300h07Edgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:HLVXHilleVax Inc
10/06/202300h34Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:HLVXHilleVax Inc
12/05/202322h56Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:HLVXHilleVax Inc
12/05/202322h18Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:HLVXHilleVax Inc
12/05/202322h05GlobeNewswire Inc.HilleVax Reports First Quarter 2023 Financial Results and Highlights Recent Company ProgressNASDAQ:HLVXHilleVax Inc
10/05/202322h14Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:HLVXHilleVax Inc
09/05/202313h00GlobeNewswire Inc.HilleVax Announces Appointment of Nanette Cocero Ph.D., MBA, to its Board of DirectorsNASDAQ:HLVXHilleVax Inc
28/04/202322h46Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:HLVXHilleVax Inc
 Showing the most relevant articles for your search:NASDAQ:HLVX

Dernières Valeurs Consultées

EU
RI
Pernod Ricard
NYSE
JPM
JP Morgan Chase
NYSE
DIS
Walt Disney
EU
BEL20
Bel 20
EU
DG
Vinci
FTSE
UKX
FTSE 100
COIN
ETHUSD
Ethereum
EU
HO
Thales
NASDAQ
GOOGL
Alphabet
EU
LR
Legrand
EU
AI
Air Liquide
EU
VIV
Vivendi
SPI
SP500
S&P 500
NASDAQ
NVDA
NVIDIA
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés